T cell receptor peptide vaccination in rheumatoid arthritis: A placebo- controlled trial using a combination of V(β)3, V(β)14, and V(β)17 peptides

Arthritis and Rheumatism

Volumn 41, Issue 11, 1998, Pages 1919-1929

  Moreland, Larry W ^a   Morgan, Elizabeth E ^b   Adamson III, Thomas C ^c   Fronek, Zdenka ^c   Calabrese, Leonard H ^d   Cash, Joseph M ^a   Markenson, Joseph A ^e,i   Matsumoto, Alan K ^f   Bathon, Joan ^f   Matteson, Eric L ^g   Uramoto, Kristine M ^g   Weyand, Cornelia M ^g   Koopman, William J ^a   Heck, Louis W ^a   Strand, Vibeke ^b,h   Diveley, Jocelyn P ^b   Carlo, Dennis J ^b   Nardo, Christopher J ^b   Richieri, Steven P ^b   Brostoff, Steven W ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Orchestra Therapeutics Inc   (United States)

^c Sharp Rees Stealy Medical Group   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e HOSPITAL FOR SPECIAL SURGERY   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g MAYO CLINIC   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; PLACEBO; T LYMPHOCYTE RECEPTOR;

ARTICLE; AUTOIMMUNE DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MONITORING; DRUG TOLERANCE; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTICENTER STUDY; PATHOGENESIS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; VACCINATION;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; DOUBLE-BLIND METHOD; FEMALE; FREUND'S ADJUVANT; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; VACCINATION;

EID: 17344364795     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199811)41:11<1919::AID-ART5>3.0.CO;2-1     Document Type: Article

References (11)

1. Harris ED Jr. Rheumatoid arthritis: Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Koopman WJ, Gay S. Do nonimmunologically mediated pathways play a role in the pathogenesis of rheumatoid arthritis? Rheum Dis Clin North Am 1993;19:107-22.
3. Nepom GT, Erlich H. MHC class II molecules and autoimmunity. Annu Rev Immunol 1991;9:493-525.
4. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994;56:389-466.
5. Zagon G, Tumang JR, Li Y, Friedman SM, Crow MK. Increased frequency of Vβ17-positive T cells in patients with rheumatoid arthritis. Arthritis Rheum 1994;37:1431-40.
6. Goronzy JJ, Bartz-Bazzanella P, Hu W, Jendro MC, Walser-Kuntz DR, Weyand CM. Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis. J Clin Invest 1994;94:2068-76.
7. Paliard X, West S, Lafferty J, Clements JR, Kappler JW, Marrack P, et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991;253:325-9.
8. Bucht A, Oksenberg JR, Lindblad S, Gronberg A, Steinman L, Klareskog L. Characterization of T cell receptor β repertoire in synovial tissue from different temporal phases of rheumatoid arthritis. Scand J Immunol 1992;35:159-65.
9. Jenkins RN, Nikaein A, Zimmermann A, Meek K, Lipsky PE. T cell receptor Vβ gene bias in rheumatoid arthritis. J Clin Invest 1993;92:2688-701.
10. Williams WV, Fang Q, Demarco D, von Feldt J, Zurier RB, Weiner DB. Restricted heterogeneity of T cell receptor transcripts in rheumatoid synovium. J Clin Invest 1992;90:326-33.
11. Howell MD, Diveley JP, Lundeen KA, Esty A, Winters ST, Carlo DJ, et al. Limited T cell receptor β-chain heterogeneity among interleukin-2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. Proc Natl Acad Sci U S A 1991;88:10921-5.